感染性主动脉瘤管理的系统综述
开放手术修复占58%,血管腔内修复占39%,单纯药物治疗占3%。腹主动脉感染者EVAR短期生存优于开放手术,术后抗生素超过6个月与更好生存相关,感染相关并发症发生率为21%且46%-70%致命。
要点
- 腹主动脉感染性动脉瘤EVAR短期生存优于开放手术,且无晚期劣势
- 术后抗生素治疗超过6个月与更好生存相关,但疗程无共识
- 感染相关并发症发生率为21%,其中46%-70%致命
核心结论
- EVAR与开放手术相比短期生存更优且无晚期劣势,可作为可接受的替代方案。
- 感染性主动脉瘤治疗须个体化制定,通用推荐不适用。
- 感染相关并发症对术后患者构成重大威胁,需进一步研究。
研究设计与样本
- 系统文献综述,检索MEDLINE和ScienceDirect数据库2000年1月至2018年9月发表文献。
- 采用PRISMA声明筛选文献,因异质性和数据缺失未行meta分析。
主要发现
- 总体治疗:开放手术修复556例(58%),EVAR 373例(39%),单纯药物治疗34例(3%)。
- 2010年前开放手术为主导,之后转向EVAR。
- 腹主动脉感染性动脉瘤中EVAR短期生存优于开放手术。
- 术后抗生素超过6个月与更好生存相关,但疗程无共识。
- 感染相关并发症发生率21%,与手术技术无关,其中46%-70%致命。
关键数值与推荐
- 不良结局相关因素:年龄增长、破裂、肾上腹主动脉瘤位置、非沙门菌阳性培养。
- 术后抗生素治疗超过6个月与更好生存相关。
- 感染相关并发症发生率21%,其中46%-70%致命。
临床怎么用
- EVAR可作为开放手术的可接受替代方案,尤其适用于腹主动脉感染性动脉瘤。
- 术后抗生素治疗应考虑超过6个月,但需个体化确定疗程。
- 治疗决策须根据患者具体情况个体化制定,不应套用通用推荐。
局限性
- 文献主要为小型回顾性单中心研究。
- 患者和研究异质性大,数据缺失,无法进行meta分析。
- 需要标准化报告以提高研究可比性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of this systematic literature review was to compile an updated overview of mycotic aortic aneurysm (MAA) treatment and outcomes. METHODS: A systematic literature review was performed using the search terms mycotic and infected aortic aneurysms in the MEDLINE and ScienceDirect databases, published between January 2000 and September 2018. Using the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, articles were scrutinised regarding surgical technique, aortic segment involved, pre- and post-operative antibiotic regimens, survival and infection related complications (IRCs), and factors associated with adverse or favourable outcomes. RESULTS: Twenty-eight studies, with a total of 963 patients, were included. All publications were observational, retrospective studies. Patient and study heterogeneity, along with missing data, precluded meta-analyses. Overall treatment consisted of open surgical repair (OSR; n = 556 [58%]), endovascular aortic repair (EVAR; n = 373 [39%]), and medical treatment alone (n = 34 [3%]). OSR was the dominant surgical technique prior to 2010, shifting to EVAR thereafter. For MAAs located in the abdominal aorta, EVAR was associated with better short term survival than OSR. Antibiotic treatment for more than six months post-operatively was associated with better survival, but there was no consensus on the length of treatment. MAAs were complicated by IRCs in 21%, irrespective of surgical technique, of which 46%-70% were fatal. The most consistently reported factors associated with adverse outcomes were increasing age, rupture, suprarenal abdominal aneurysm location, and non-Salmonella positive culture. CONCLUSIONS: With few exceptions, the literature mainly consists of small, retrospective single centre studies. Standardised reporting is needed to increase comparability of studies. EVAR appears to be associated with superior short term survival without late disadvantages, compared with OSR. This suggests that EVAR can be an acceptable alternative to OSR. However, MAA treatment should always be tailor made and planned individually, and general recommendations are in vain. IRCs pose a significant threat to patients after MAA repair and require further investigation.
引用
- Sörelius K, Budtz-Lilly J, Mani K, et al. Systematic Review of the Management of Mycotic Aortic Aneurysms. Eur J Vasc Endovasc Surg. 2019. PMID: 31320247. doi:10.1016/j.ejvs.2019.05.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。